Siddharth mittal, Author

Biopharmaceutical major Biocon Ltd and Swiss market expansion services group Diethelm Keller Siber Hegner (DKSH) said on Monday their subsidiaries have signed an agreement under which DKSH will sell and distribute seven of Biocon Pharma's generic formulations in Singapore and Thailand.Under the terms of the agreement, DKSH will gain an exclusive license to register and commercialise these seven generic formulations from various therapeutic areas like diabetology, cardiology, oncology and immunology which will be sold under Biocon's brand in Singapore and Thailand.DKSH will manage marketing and sales as well as logistics for Biocon Pharma, helping drive sales growth through its capabilities and strengths in the medical and pharmacy channels. The development is in line with Biocon's strategy for expansion of its generic formulations business through licensing of its drug products in multiple markets."This collaboration will enable us to address the growing patient needs for affordable access to high-quality generics for chronic diseases and expand our commercial footprint in this region," said Biocon's CEO and Managing Director Siddharth Mittal."Our generic formulations pipeline comprises of difficult-to-make, complex molecules and leverages our strong track record of quality and reliability of supplies to our patients and customers," he said in a statement.Bijay Singh, Global Head of Business Unit Healthcare at DKSH, said: "With a broad reach across our medical channel in Asia, we are committed to driving growth for Biocon Pharma and improving access to healthcare products for all."Biocon's generic formulations business is built on the back of the company's strong portfolio of complex and differentiated active pharma ingredients. Through forward integration into dosage forms, the company seeks to provide an efficacious and continuous supply of high-quality affordable drugs to address patient needs in diverse markets.The company has successfully commercialised a few products under its own label in the United States.( With inputs from ANI )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Salman Khan

Siddharth MittalFOLLOW

Siddharth mittal, Latest News

Business :Pharma firm Biocon's Q4 net profits up 31 pc; announces dividend for investors

New Delhi [India], May 24 : Global biopharmaceuticals company Biocon has announced its consolidated financial results for the fourth ... ...

Business :Biocon appoints Anupam Jindal as new CFO

Biocon Ltd has appointed Anupam Jindal as the new Chief Financial Officer (CFO) and be part of the executive leadership team. ...

Business :Biocon, DKSH collaborate to commercialise 7 generic formulations in SE Asia

Biopharmaceutical major Biocon Ltd and Swiss market expansion services group Diethelm Keller Siber Hegner (DKSH) said on Monday their subsidiaries have signed an agreement under which DKSH will sell and distribute seven of Biocon Pharma's generic for ...